| Harish Seethamraju, MD | |
|
740 S Limestone, A301, Lexington, KY 40536-0284 | |
| (859) 323-6494 | |
| (859) 257-4682 |
| Full Name | Harish Seethamraju |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 30 Years |
| Location | 740 S Limestone, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417037847 | NPI | - | NPPES |
| 163955101 | Medicaid | TX | |
| 1417037847 | Other | TX | BLUE CROSS BLUE SHIELD |
| 163955103 | Medicaid | TX | |
| 1807842 | Other | LA | LA MEDICAID |
| P01023534 | Other | TX | MEDICARE RR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | L7879 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Sinai Hospital | New york, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Icahn School Of Medicine At Mount Sinai | 2264691070 | 2339 |
News Archive
The coronavirus doesn't spread uniformly through a community.But in the world of disease modeling, many projections take a high-level approach to a geographic area, like a county or state, and forecast based on a general idea that a virus will take root and spread at an equal rate until it reaches its peak of infection.
AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnife® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.
Ekahau Inc., the world's leading provider of high-performance Wi-Fi based real-time locating systems (RTLS) and tools, announced today that German hospital Westküstenklinikum Heide (WKK) is using Ekahau technology to assure the safety of its psychiatric- and night-duty staff, and to track the locations of wheelchairs.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.
"A committee of the International Commission on Non-Ionizing Radiation Protection has concluded after a comprehensive review that there is little cause for concern about the suggested link between mobile phone use and brain tumours," BMJ reports.
› Verified 8 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
The coronavirus doesn't spread uniformly through a community.But in the world of disease modeling, many projections take a high-level approach to a geographic area, like a county or state, and forecast based on a general idea that a virus will take root and spread at an equal rate until it reaches its peak of infection.
AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnife® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.
Ekahau Inc., the world's leading provider of high-performance Wi-Fi based real-time locating systems (RTLS) and tools, announced today that German hospital Westküstenklinikum Heide (WKK) is using Ekahau technology to assure the safety of its psychiatric- and night-duty staff, and to track the locations of wheelchairs.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.
"A committee of the International Commission on Non-Ionizing Radiation Protection has concluded after a comprehensive review that there is little cause for concern about the suggested link between mobile phone use and brain tumours," BMJ reports.
› Verified 8 days ago
| Entity Name | Icahn School Of Medicine At Mount Sinai |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275802811 PECOS PAC ID: 2264691070 Enrollment ID: O20120315000035 |
News Archive
The coronavirus doesn't spread uniformly through a community.But in the world of disease modeling, many projections take a high-level approach to a geographic area, like a county or state, and forecast based on a general idea that a virus will take root and spread at an equal rate until it reaches its peak of infection.
AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnife® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.
Ekahau Inc., the world's leading provider of high-performance Wi-Fi based real-time locating systems (RTLS) and tools, announced today that German hospital Westküstenklinikum Heide (WKK) is using Ekahau technology to assure the safety of its psychiatric- and night-duty staff, and to track the locations of wheelchairs.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.
"A committee of the International Commission on Non-Ionizing Radiation Protection has concluded after a comprehensive review that there is little cause for concern about the suggested link between mobile phone use and brain tumours," BMJ reports.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Harish Seethamraju, MD 740 S Limestone, A301, Lexington, KY 40536-0284 Ph: (859) 323-6494 | Harish Seethamraju, MD 740 S Limestone, A301, Lexington, KY 40536-0284 Ph: (859) 323-6494 |
News Archive
The coronavirus doesn't spread uniformly through a community.But in the world of disease modeling, many projections take a high-level approach to a geographic area, like a county or state, and forecast based on a general idea that a virus will take root and spread at an equal rate until it reaches its peak of infection.
AngioDynamics today announced the first patient treatment and growing enrollment in a pilot study of the use of the Company's NanoKnife® Irreversible Electroporation (IRE) System in the treatment of early stage hepatocellular carcinoma (HCC), or primary liver cancer. This clinical trial is being conducted under the supervision of Professor Jordi Bruix of the Barcelona Clinic Liver Cancer Group of the University of Barcelona and Professor Riccardo Lencioni of the University of Pisa School of Medicine.
Ekahau Inc., the world's leading provider of high-performance Wi-Fi based real-time locating systems (RTLS) and tools, announced today that German hospital Westküstenklinikum Heide (WKK) is using Ekahau technology to assure the safety of its psychiatric- and night-duty staff, and to track the locations of wheelchairs.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced the Canadian launch of ABLAVAR (gadofosveset trisodium injection), a unique, injectable magnetic resonance angiography (MRA) blood pool imaging agent.
"A committee of the International Commission on Non-Ionizing Radiation Protection has concluded after a comprehensive review that there is little cause for concern about the suggested link between mobile phone use and brain tumours," BMJ reports.
› Verified 8 days ago
Mr. Fabrizio Canepa Escaro, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Uk Division Of Hospital Medicine 800 Rose, Lexington, KY 40536 Phone: 859-323-6047 Fax: 859-257-3873 | |
Dr. Moneera Nur Haque, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 125 E Maxwell St Ste 200, Lexington, KY 40508 Phone: 859-323-3231 Fax: 859-257-9461 | |
Dr. Indhira Bisono Jimenez, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 211 Fountain Ct, Suite 220, Lexington, KY 40509 Phone: 859-629-7265 Fax: 859-629-7266 | |
Deepali Pandey, MBBS Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 800 Rose St # Cc-402, Lexington, KY 40536 Phone: 650-804-3111 | |
Dr. Dorothy Mccord Maes, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1000 S Limestone, Lexington, KY 40536 Phone: 859-323-9057 Fax: 859-323-9502 | |
Dr. Stephen M Mooney, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2101 Nicholasville Rd Ste 304, Lexington, KY 40503 Phone: 859-277-5771 Fax: 859-276-4622 | |
Michael Han Young, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 740 S Limestone, Lexington, KY 40536 Phone: 859-323-5544 Fax: 859-257-9286 |